30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

Wright Medical Posts 2Q16 Revenue -

Wright Medical (WMGI) reported 2Q16 revenue of US $170.7MM, +13.7% from 2Q15. (U.S. $121.9MM, +15.6%; ex-U.S. $48.8MM, +9%) Revenue excludes discontinued operations. Growth is as reported.

ORTHOWORLD estimates 2Q16 segment sales and growth on an as-reported basis, as follows.

  • Joint Reconstruction Extremities $76.7MM, +13.9%
  • Trauma $65.4MM, +9.4%
  • Arthroscopy/Soft Tissue Repair $6.0MM, +0.4%
  • Orthobiologics $22.7MM, +32.2%

ORTHOWORLD estimates are based on WMGI's reported pro forma revenue. For 2Q16, WMGI reported pro forma sales excluding discontinued operations, i.e. Tornier's large joint assets that are to be acquired by Corin by 4Q16. For 2Q16, revenue from these assets was $10.2MM. Thus, had this been included, 2Q16 net sales would have been $180.9MM.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.